Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 105 citing Bowker: Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylurea.... (0.09 sec) 

Glucose metabolism and cancer

- brain-treatments.net [PDF] 
RJ Shaw - Current opinion in cell biology, 2006 - Elsevier
The first identified biochemical hallmark of tumor cells was a shift in glucose
metabolism from oxidative phosphorylation to aerobic glycolysis. We now know
that much of this metabolic conversion is controlled by specific ...
Cited by 105 - Related articles - All 7 versions

AMPK and cell proliferation–AMPK as a therapeutic target for atherosclerosis and cancer


H Motoshima, BJ Goldstein, M Igata, E Araki - The Journal of physiology, 2006 - Physiological Soc
AMPK is a serine/threonine protein kinase, which serves as an energy sensor in
all eukaryotic cell types. Published studies indicate that AMPK activation
strongly suppresses cell proliferation in non-malignant cells as well as in ...
Cited by 91 - Related articles - BL Direct - All 9 versions

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells


M Zakikhani, R Dowling, IG Fantus, N … - Cancer Research, 2006 - AACR
Metformin (1,1-dimethylbiguanide hydrochloride) is a biguanide commonly used in
the treatment of type 2 diabetes mellitus (1). It is frequently referred to as
an "insulin sensitizer" because in settings of insulin resistance and ...
Cited by 75 - Related articles - BL Direct - All 7 versions

Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention …


Z Gong, ML Neuhouser, PJ Goodman, D … - Cancer Epidemiology Biomarkers & Prevention, 2006 - AACR
Many studies have examined the role of obesity in prostate cancer etiology, but
their results have been conflicting and inconclusive (1, 2). Most studies have
found no association between obesity and prostate cancer incidence (1, 3, ...
Cited by 67 - Related articles - BL Direct - All 7 versions

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient …


M Buzzai, RG Jones, RK Amaravadi, JJ Lum, … - Cancer Research, 2007 - AACR
Beyond the reported effects of metformin on insulin-responsive tissues, little
is known about the effects of metformin on other cell types. However, AMPK is a
intracellular fuel sensor that regulates cellular homeostasis in response ...
Cited by 61 - Related articles - BL Direct - All 5 versions

Insulin and insulin-like growth factor signalling in neoplasia

- mcgill.ca [PDF] 
M Pollak - Nat Rev Cancer, 2008 - canadiancpd.medscape.com
Insulin and insulin-like growth factors (IGFs) are well known as key regulators
of energy metabolism and growth. There is now considerable evidence that these
hormones and the signal transduction networks they regulate have important ...
Cited by 46 - Related articles - All 10 versions

The role of insulin receptors and IGF-I receptors in cancer and other diseases


F Frasca, G Pandini, L Sciacca, V Pezzino, S … - Archives of physiology and biochemistry, 2008 - informahealthcare.com
There is evidence, both in vitro and in vivo, that receptor tyrosine kinases
play a key role in the formation and progression of human cancer. In particular,
the insulin-like growth factor receptor (IGF-IR), a tyrosine kinase ...
Cited by 33 - Related articles - BL Direct - All 6 versions

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

- easd.org [PDF] 
CJ Currie, CD Poole, EAM Gale - Diabetologia, 2009 - Springer
Abstract Aims/hypothesis The risk of developing a range of solid tumours is
increased in type 2 diabetes, and may be influenced by glucose-lowering
therapies. We examined the risk of development of solid tumours in relation ...
Cited by 34 - Related articles - All 9 versions

The LKB1 tumor suppressor kinase in human disease


P Katajisto, T Vallenius, K Vaahtomeri, N … - BBA-Reviews on Cancer, 2007 - Elsevier
Inactivating germline mutations in the LKB1 gene underlie Peutz–Jeghers
syndrome characterized by hamartomatous polyps and an elevated risk for cancer.
Recent studies suggest the involvement of LKB1 also in more common human ...
Cited by 29 - Related articles - All 5 versions

Cellular energy sensing and signaling by AMP-activated protein kinase


WW Winder, DM Thomson - Cell Biochemistry and Biophysics, 2007 - Springer
Abstract AMP-activated protein kinase (AMPK) is an energy sensing/signaling
protein that, when activated, increases ATP production by stimulating glucose
uptake and fatty acid oxidation while at the same time inhibiting ATP ¼ ...
Cited by 24 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google